iRhythm Technologies, Inc.
NASDAQ:IRTCMedical - Devices
+$0.36 today
- Market cap
- $3.19B
- Beta
- 1.28
- P/E (TTM)
- -119.5
- EPS (TTM)
- -$0.85
Volume 1.20M
Average 0.52M
IRTC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
iRhythm Technologies, Inc.NASDAQ: IRTC
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income growth accelerates
Q3 FY2026 net income of $29.85M (cash outflow) rose 472.7% year over year, ahead of the -25.0% change in trailing-twelve-month net income. Sequentially, it rose 7734.9% from the prior quarter. Over 3 fiscal years it compounded at -27.3% a year.
Context
- Net income amounted to 6.0% of revenue in FY2025, down 13.2 pp from a year earlier.
- Net income grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 11 analysts of -$1.98M (-95.6%) for the fiscal year ending Dec 2026, a slowdown from the -60.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$29.85M+7734.9% QoQ
- Last fiscal yearDec 2025
- -$44.55M-60.7% YoY
- LTMSep 2026
- -$38.59M-25.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +472.7% | -6.2% | -478.9 pp |
| 1 year | -60.7% | -95.6% | -34.9 pp |
| 3-year CAGR | -27.3% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (44.55M) USD
- Year-over-year change
- +60.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (44.55M) | +60.7% |
| FY2024 | 2024-12-31 | (113.29M) | +8.2% |
| FY2023 | 2023-12-31 | (123.41M) | -6.2% |
| FY2022 | 2022-12-31 | (116.16M) | -14.6% |
| FY2021 | 2021-12-31 | (101.36M) | — |
Net Income vs competitors
How IRTC compares with its peers on the latest reported figures
- IRTC's LTM Sep 2026 net income of $38.59M is the 6th largest of the 7 companies compared; the peer median is $178.33M.
- Its year-over-year change of -25.0% is the lowest of 7, against a peer median of +51.9%.
- Net income amounts to 4.5% of revenue for IRTC, versus a peer median of 13.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $5.27B | +12.7% | +8.5% | 14.0% | |
| LTM Jun 2026 | $3.67B | +34.6% | +60.6% | 17.5% | |
| LTM Sep 2026 | $196.07M | +190.2% | +41.2% | 13.0% | |
| LTM Jun 2026 | $160.59M | +8.7% | — | 10.7% | |
| LTM Jan 2026 | $143.89M | +69.3% | — | 171.9% | |
| LTM Sep 2026 | $38.59M | -25.0% | -27.3% | 4.5% | |
| LTM Jun 2026 | $10.55M | +129.0% | -37.3% | 1.9% | |
| Peer median (excluding IRTC) | $178.33M | +51.9% | +24.8% | 13.5% | |
Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (101.36M) | (116.16M) | (123.41M) | (113.29M) | (44.55M) |
| Depreciation & Amortization | 16.59M | 19.61M | 22.14M | 25.78M | 26.48M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 54.53M | 57.74M | 77.2M | 75.98M | 88.28M |
| Change in Working Capital | (46.23M) | (65.51M) | (102.05M) | (99.12M) | (91.7M) |
| Accounts Receivables | (53.57M) | (61.84M) | (81.19M) | (91.92M) | (95.43M) |
| Inventory | (4.96M) | (5.11M) | 979K | (224K) | (8.51M) |
| Accounts Payables | 6.14M | (2.99M) | (1.97M) | 0 | 28.04M |
| Other Working Capital | 6.17M | 4.43M | (19.86M) | (6.97M) | (15.8M) |
| Other Non-Cash Items | 38.72M | 81.3M | 76M | 114.04M | 102.35M |
| Operating Cash Flow | (37.75M) | (23.01M) | (50.1M) | 3.39M | 80.86M |
| Capital Expenditures | (28.07M) | (29.83M) | (40.42M) | (48.94M) | (46.34M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (122.18M) | (188.57M) | (167.29M) | (175.24M) | (468.41M) |
| Sales of Investments | 255.52M | 165.97M | 206.5M | 101.2M | 237.7M |
| Other Investing Activities | 0 | 0 | 0 | (15M) | 0 |
| Investing Cash Flow | 105.26M | (52.43M) | (1.21M) | (122.98M) | (277.06M) |
| Debt Repayment | (11.67M) | 13.53M | 0 | 619.84M | 0 |
| Common Stock Issued | 8.94M | 0 | 0 | 8.47M | 12.61M |
| Common Stock Repurchased | 0 | 0 | 0 | (25M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (25.85M) | 13.18M | 8.82M | (91.93M) | 0 |
| Financing Cash Flow | (28.58M) | 26.72M | 8.82M | 511.38M | 12.61M |
| Effect of Forex Changes | 0 | 0 | (169K) | (6K) | 1K |
| Net Change in Cash | 38.93M | (48.73M) | (42.66M) | 391.78M | (183.59M) |
| Free Cash Flow | (65.82M) | (52.84M) | (90.53M) | (45.55M) | 34.52M |
iRhythm Technologies, Inc.
NASDAQ:IRTC
Intrinsic Alpha fair value
Locked
Current Price
$94.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.